title: Targeting RIPK1,2,3 to combat inflammation.
authors.affiliation: Structural Genomics Consortium, University of Oxford, Old Road Campus, Oxford, UK.
authors.forename: Alex N
authors.initials: AN
authors.lastname: Bullock
authors.affiliation: Department of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
authors.forename: Alexei
authors.initials: A
authors.lastname: Degterev
mesh_terms: D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007249:Inflammation / Q000276:immunology*; D053475:Receptor-Interacting Protein Serine-Threonine Kinase 2 / Q000378:metabolism*; D053422:Receptor-Interacting Protein Serine-Threonine Kinases / Q000378:metabolism*
chemical_list: C506249:RIPK1 protein, human; C506253:RIPK2 protein, human; C119705:RIPK3 protein, human; D053475:Receptor-Interacting Protein Serine-Threonine Kinase 2; D053422:Receptor-Interacting Protein Serine-Threonine Kinases
keywords: RIPK1; RIPK2; RIPK3; inflammation; necroptosis